| First Author | Wilson TJ | Year | 2020 |
| Journal | Immunology | Volume | 159 |
| Issue | 4 | Pages | 393-403 |
| PubMed ID | 31880316 | Mgi Jnum | J:287258 |
| Mgi Id | MGI:6415747 | Doi | 10.1111/imm.13169 |
| Citation | Wilson TJ, et al. (2020) Signalling lymphocyte activation molecule family member 9 is found on select subsets of antigen-presenting cells and promotes resistance to Salmonella infection. Immunology 159(4):393-403 |
| abstractText | Signalling lymphocyte activation molecule family member 9 (SLAMF9) is an orphan receptor of the CD2/SLAM family of leucocyte surface proteins. Examination of SLAMF9 expression and function indicates that SLAMF9 promotes inflammation by specialized subsets of antigen-presenting cells. Within healthy liver and circulating mouse peripheral blood mononuclear cells, SLAMF9 is expressed on CD11b(+) , Ly6C(-) , CD11c(low) , F4/80(low) , MHC-II(+) , CX3 CR1(+) mononuclear phagocytes as well as plasmacytoid dendritic cells. In addition, SLAMF9 can be found on peritoneal B1 cells and small (F4/80(low) ), but not large (F4/80(high) ), peritoneal macrophages. Upon systemic challenge with Salmonella enterica Typhimurium, Slamf9(-/-) mice were impaired in their ability to clear the infection from the liver. In humans, SLAMF9 is up-regulated upon differentiation of monocytes into macrophages, and lipopolysaccharide stimulation of PMA-differentiated, SLAMF9 knockdown THP-1 cells showed an essential role of SLAMF9 in production of granulocyte-macrophage colony-stimulating factor, tumour necrosis factor-alpha, and interleukin-1beta. Taken together, these data implicate SLAMF9 in the initiation of inflammation and clearance of bacterial infection. |
